ORIC Pharmaceuticals, Inc. (ORIC) Misses Q2 EPS by 2c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q2 EPS of ($0.38), $0.02 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
• Raytheon wins $42.5M Navy air traffic contract